Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients

Ads

You May Also Like

Advanced Accelerator Applications Announces Presentation of Quality of Life Findings from NETTER-1 Phase III Study at ENETS

SAINT-GENIS-POUILLY, France, March 06, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” ...

Innate Pharma presents new CD73 checkpoint inhibitor program

Novel antibodies identified that block the CD73 immune checkpoint for cancer immunotherapy; Strengthens Innate's ...

Avant Diagnostics to Present at Upcoming Investor Conferences

SCOTTSDALE, Ariz. and GAITHERSBERG, Md., May 31, 2016 (GLOBE NEWSWIRE) -- Avant Diagnostics, Inc. ...